REPORT ID 6625

Asia-Pacific ADHD Drugs Market Report 2017

Publish Date
26-Dec-17
Pages
104
Format
Electronic (PDF)

In this report, the Asia-Pacific ADHD Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of ADHD Drugs for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific ADHD Drugs market competition by top manufacturers/players, with ADHD Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Eli Lilly
    Janssen Pharmaceuticals, Inc.
    Shire
    Perdue Pharma
    Glaxosmith Kline
    Novartis
    Celltech Group
    Johnson & Johnson

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Stimulants (Amphetamines, Methylphenidate)
    Non-Stimulants
    Antidepressants
    Blood Pressure Medicines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Adults
    Children

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific ADHD Drugs Market Report 2017
1 ADHD Drugs Overview
    1.1 Product Overview and Scope of ADHD Drugs
    1.2 Classification of ADHD Drugs by Product Category
        1.2.1 Asia-Pacific ADHD Drugs Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific ADHD Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Stimulants (Amphetamines, Methylphenidate)
        1.2.4 Non-Stimulants
        1.2.5 Antidepressants
        1.2.6 Blood Pressure Medicines
    1.3 Asia-Pacific ADHD Drugs Market by Application/End Users
        1.3.1 Asia-Pacific ADHD Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Adults
        1.3.3 Children
    1.4 Asia-Pacific ADHD Drugs Market by Region
        1.4.1 Asia-Pacific ADHD Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of ADHD Drugs (2012-2022)
        1.5.1 Asia-Pacific ADHD Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific ADHD Drugs Revenue and Growth Rate (2012-2022)

2 Asia-Pacific ADHD Drugs Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific ADHD Drugs Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific ADHD Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific ADHD Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific ADHD Drugs (Volume and Value) by Type
        2.2.1 Asia-Pacific ADHD Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific ADHD Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific ADHD Drugs (Volume) by Application
    2.4 Asia-Pacific ADHD Drugs (Volume and Value) by Region
        2.4.1 Asia-Pacific ADHD Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific ADHD Drugs Revenue and Market Share by Region (2012-2017)

3 China ADHD Drugs (Volume, Value and Sales Price)
    3.1 China ADHD Drugs Sales and Value (2012-2017)
        3.1.1 China ADHD Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 China ADHD Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 China ADHD Drugs Sales Price Trend (2012-2017)
    3.2 China ADHD Drugs Sales Volume and Market Share by Type
    3.3 China ADHD Drugs Sales Volume and Market Share by Application

4 Japan ADHD Drugs (Volume, Value and Sales Price)
    4.1 Japan ADHD Drugs Sales and Value (2012-2017)
        4.1.1 Japan ADHD Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan ADHD Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 Japan ADHD Drugs Sales Price Trend (2012-2017)
    4.2 Japan ADHD Drugs Sales Volume and Market Share by Type
    4.3 Japan ADHD Drugs Sales Volume and Market Share by Application

5 South Korea ADHD Drugs (Volume, Value and Sales Price)
    5.1 South Korea ADHD Drugs Sales and Value (2012-2017)
        5.1.1 South Korea ADHD Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea ADHD Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea ADHD Drugs Sales Price Trend (2012-2017)
    5.2 South Korea ADHD Drugs Sales Volume and Market Share by Type
    5.3 South Korea ADHD Drugs Sales Volume and Market Share by Application

6 Taiwan ADHD Drugs (Volume, Value and Sales Price)
    6.1 Taiwan ADHD Drugs Sales and Value (2012-2017)
        6.1.1 Taiwan ADHD Drugs Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan ADHD Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan ADHD Drugs Sales Price Trend (2012-2017)
    6.2 Taiwan ADHD Drugs Sales Volume and Market Share by Type
    6.3 Taiwan ADHD Drugs Sales Volume and Market Share by Application

7 India ADHD Drugs (Volume, Value and Sales Price)
    7.1 India ADHD Drugs Sales and Value (2012-2017)
        7.1.1 India ADHD Drugs Sales Volume and Growth Rate (2012-2017)
        7.1.2 India ADHD Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 India ADHD Drugs Sales Price Trend (2012-2017)
    7.2 India ADHD Drugs Sales Volume and Market Share by Type
    7.3 India ADHD Drugs Sales Volume and Market Share by Application

8 Southeast Asia ADHD Drugs (Volume, Value and Sales Price)
    8.1 Southeast Asia ADHD Drugs Sales and Value (2012-2017)
        8.1.1 Southeast Asia ADHD Drugs Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia ADHD Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia ADHD Drugs Sales Price Trend (2012-2017)
    8.2 Southeast Asia ADHD Drugs Sales Volume and Market Share by Type
    8.3 Southeast Asia ADHD Drugs Sales Volume and Market Share by Application

9 Australia ADHD Drugs (Volume, Value and Sales Price)
    9.1 Australia ADHD Drugs Sales and Value (2012-2017)
        9.1.1 Australia ADHD Drugs Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia ADHD Drugs Revenue and Growth Rate (2012-2017)
        9.1.3 Australia ADHD Drugs Sales Price Trend (2012-2017)
    9.2 Australia ADHD Drugs Sales Volume and Market Share by Type
    9.3 Australia ADHD Drugs Sales Volume and Market Share by Application

10 Asia-Pacific ADHD Drugs Players/Suppliers Profiles and Sales Data
    10.1 Eli Lilly
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 ADHD Drugs Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Eli Lilly ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Janssen Pharmaceuticals, Inc.
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 ADHD Drugs Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Janssen Pharmaceuticals, Inc. ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Shire
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 ADHD Drugs Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Shire ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Perdue Pharma
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 ADHD Drugs Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Perdue Pharma ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Glaxosmith Kline
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 ADHD Drugs Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Glaxosmith Kline ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Novartis
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 ADHD Drugs Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Novartis ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Celltech Group
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 ADHD Drugs Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Celltech Group ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Johnson & Johnson
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 ADHD Drugs Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Johnson & Johnson ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview

11 ADHD Drugs Manufacturing Cost Analysis
    11.1 ADHD Drugs Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of ADHD Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 ADHD Drugs Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of ADHD Drugs Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific ADHD Drugs Market Forecast (2017-2022)
    15.1 Asia-Pacific ADHD Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific ADHD Drugs Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific ADHD Drugs Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific ADHD Drugs Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific ADHD Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific ADHD Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific ADHD Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China ADHD Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan ADHD Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea ADHD Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan ADHD Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India ADHD Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia ADHD Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia ADHD Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific ADHD Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific ADHD Drugs Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific ADHD Drugs Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific ADHD Drugs Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific ADHD Drugs Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer